Mari Yokoi, Atsushi Yonezawa, Daiki Hira, Tomohiro Handa, Kiminobu Tanizawa, Shunsaku Nakagawa, . . . Tomohiro Terada. (2024). Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: A single-center retrospective study. BMC.
Chicago Style (17th ed.) CitationMari Yokoi, et al. Subjective Symptoms Are Triggers for the Detection of Immune Checkpoint Inhibitor-induced Interstitial Lung Disease and Associate with Disease Severity: A Single-center Retrospective Study. BMC, 2024.
MLA (9th ed.) CitationMari Yokoi, et al. Subjective Symptoms Are Triggers for the Detection of Immune Checkpoint Inhibitor-induced Interstitial Lung Disease and Associate with Disease Severity: A Single-center Retrospective Study. BMC, 2024.